A review of the therapeutic management of Crohn's disease

被引:32
作者
Kumar, Aditi [1 ]
Cole, Alexander [2 ]
Segal, Jonathan [3 ]
Smith, Philip [4 ,5 ]
Limdi, Jimmy K. [6 ,7 ]
机构
[1] Royal Wolverhampton NHS Trust, Dept Gastroenterol, Wolverhampton WV10 0QP, England
[2] Imperial Coll Healthcare NHS Trust, London, England
[3] St Marys Hosp, Dept Gastroenterol & Hepatol, London, England
[4] Liverpool Univ Hosp NHS Fdn Trust, Royal Liverpool & Broadgreen Univ Hosp, Dept Gastroenterol, Liverpool, Merseyside, England
[5] Univ Liverpool, Fac Med, Liverpool, Merseyside, England
[6] Northern Care Alliance NHS Fdn NHS Trust, Dept Gastroenterol, Manchester, Lancs, England
[7] Univ Manchester, Manchester Acad Hlth Sci, Manchester, Lancs, England
关键词
Crohn's disease; inflammatory bowel disease; ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; METAANALYSIS COMPARATIVE EFFICACY; DOUBLE-BLIND; MAINTENANCE THERAPY; ULCERATIVE-COLITIS; CONTROLLED-TRIAL; LONG-TERM; MAINTAINING REMISSION; MONOCLONAL-ANTIBODY;
D O I
10.1177/17562848221078456
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Crohn's disease is a chronic inflammatory, relapsing-remitting, and progressive gastrointestinal disorder with an often-negative impact on the physical, emotional, and psychological well-being. Over the past two decades, the medical compendium for the treatment of Crohn's disease has increased significantly, enabling treatment beyond symptoms. Indeed, early and timely use of effective medical therapy has been reflected by improved outcomes with reduction in surgery and ability to achieve clinical and endoscopic remission, reduce corticosteroid dependance, and prevent long-term complications in more patients. In this review, we discuss the key milestones in the medical management of Crohn's disease.
引用
收藏
页数:19
相关论文
共 118 条
[1]   Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease [J].
Akobeng, Anthony K. ;
Zhang, Dongni ;
Gordon, Morris ;
MacDonald, John K. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (09)
[2]   First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus [J].
Alkhatry, Maryam ;
Al-Rifai, Ahmad ;
Annese, Vito ;
Georgopoulos, Filippos ;
Jazzar, Ahmad N. ;
Khassouan, Ahmed M. ;
Koutoubi, Zaher ;
Nathwani, Rahul ;
Taha, Mazen S. ;
Limdi, Jimmy K. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (43) :6710-6769
[3]   Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease [J].
Baert, F ;
Noman, M ;
Vermeire, S ;
Van Assche, G ;
D'Haens, G ;
Carbonez, A ;
Rutgeerts, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :601-608
[4]   TREATMENT OF CHRONIC ULCERATIVE COLITIS WITH 6-MERCAPTOPURINE [J].
BEAN, RHD .
MEDICAL JOURNAL OF AUSTRALIA, 1962, 2 (15) :592-&
[5]   Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease [J].
Belaiche, J ;
Desager, JP ;
Horsmans, Y ;
Louis, E .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (01) :71-76
[6]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[7]   Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease [J].
Bhat, Shubha ;
Limdi, Jimmy K. ;
Cross, Raymond K. ;
Farraye, Francis A. .
DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (08) :2513-2532
[8]   Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis [J].
Bonovas, Stefanos ;
Fiorino, Gionata ;
Allocca, Mariangela ;
Lytras, Theodore ;
Nikolopoulos, Georgios K. ;
Peyrin-Biroulet, Laurent ;
Danese, Silvio .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (10) :1385-+
[9]  
BRANDT LJ, 1982, GASTROENTEROLOGY, V83, P383
[10]  
Bressler Brian, 2019, Gastroenterol Hepatol (N Y), V15, P204